Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12  (12-2014)

Period of time： 2014年12期

Publisher： Informa Healthcare

Founded in： 2005

Total resources： 64

ISSN： 1742-5255

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12

Menu

Related articles

By in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1-1

Informa Healthcare

Abstract Access to resources Recommend Favorite

Validated in vitro/in vivo correlation of prolonged-release oxycodone/naloxone with differing dissolution rates in relation to gastrointestinal transit times

By Mundin Gill E,Smith Kevin J,Mysicka Jana,Heun Gerhard,Krämer Mathias,Hahn Udo,Leuner Christian in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1495-1503

Informa Healthcare

Abstract Access to resources Recommend Favorite

The effects of gastric bypass surgery on drug absorption and pharmacokinetics

By Brocks Dion R,Ben-Eltriki Mohamed,Gabr Raniah Q,Padwal Raj S in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1505-1519

Informa Healthcare

Abstract Access to resources Recommend Favorite

Latest advances in predicting DILI in human subjects: focus on biomarkers

By Hawkins Maiyen Tran,Lewis James H in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1521-1530

Informa Healthcare

Abstract Access to resources Recommend Favorite

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

By Rangel Erika B in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1531-1548

Informa Healthcare

Abstract Access to resources Recommend Favorite

CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects

By Holstein Andreas,Beil Winfried,Kovacs Peter in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1549-1563

Informa Healthcare

Abstract Access to resources Recommend Favorite

Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs

By Nies Anne T,Damme Katja,Schaeffeler Elke,Schwab Matthias in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1565-1577

Informa Healthcare

Abstract Access to resources Recommend Favorite

Latest advances in computational genotoxicity prediction

By Naven Russell T,Greene Nigel,Williams Richard V in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1579-1587

Informa Healthcare

Abstract Access to resources Recommend Favorite

Is there a role for tirapazamine in the treatment of cervical cancer?

By Ghatage Prafull,Sabagh Hassan in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1589-1597

Informa Healthcare

Abstract Access to resources Recommend Favorite

Etoricoxib and the treatment of ankylosing spondylitis

By Lories Rik J in (2012)

Expert Opinion on Drug Metabolism and Toxicology,volume 8,issue 12 , Vol. 8, Iss. 12, 2012-12 , pp. 1599-1608

Informa Healthcare

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 11 item(s)